JP2022519789A5 - - Google Patents
Info
- Publication number
- JP2022519789A5 JP2022519789A5 JP2021569596A JP2021569596A JP2022519789A5 JP 2022519789 A5 JP2022519789 A5 JP 2022519789A5 JP 2021569596 A JP2021569596 A JP 2021569596A JP 2021569596 A JP2021569596 A JP 2021569596A JP 2022519789 A5 JP2022519789 A5 JP 2022519789A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024204631A JP2025031720A (ja) | 2019-02-06 | 2024-11-25 | カルシフェジオールを用いた副甲状腺機能亢進症の進行を制御する方法、およびそれに使用するための組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802148P | 2019-02-06 | 2019-02-06 | |
| US62/802,148 | 2019-02-06 | ||
| PCT/IB2020/000089 WO2020161543A1 (en) | 2019-02-06 | 2020-02-06 | Method of controlling progression of hyperparathyroidism with calcifediol, and compositions for use therein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024204631A Division JP2025031720A (ja) | 2019-02-06 | 2024-11-25 | カルシフェジオールを用いた副甲状腺機能亢進症の進行を制御する方法、およびそれに使用するための組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519789A JP2022519789A (ja) | 2022-03-24 |
| JP2022519789A5 true JP2022519789A5 (https=) | 2023-02-14 |
| JPWO2020161543A5 JPWO2020161543A5 (https=) | 2023-02-14 |
Family
ID=69903711
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569596A Pending JP2022519789A (ja) | 2019-02-06 | 2020-02-06 | カルシフェジオールを用いた副甲状腺機能亢進症の進行を制御する方法、およびそれに使用するための組成物 |
| JP2024204631A Pending JP2025031720A (ja) | 2019-02-06 | 2024-11-25 | カルシフェジオールを用いた副甲状腺機能亢進症の進行を制御する方法、およびそれに使用するための組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024204631A Pending JP2025031720A (ja) | 2019-02-06 | 2024-11-25 | カルシフェジオールを用いた副甲状腺機能亢進症の進行を制御する方法、およびそれに使用するための組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220226351A1 (https=) |
| EP (1) | EP3920938A1 (https=) |
| JP (2) | JP2022519789A (https=) |
| KR (1) | KR20210126023A (https=) |
| CN (1) | CN113573714A (https=) |
| AU (2) | AU2020218639A1 (https=) |
| CA (1) | CA3128153A1 (https=) |
| MX (1) | MX2020011741A (https=) |
| WO (1) | WO2020161543A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3095447T1 (sl) * | 2006-02-03 | 2022-02-28 | Opko Renal, Llc | Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3 |
| HUE037309T2 (hu) * | 2006-06-21 | 2018-08-28 | Opko Ireland Global Holdings Ltd | Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer |
| DK2148684T3 (da) | 2007-04-25 | 2013-04-22 | Cytochroma Inc | Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens |
| PT3335712T (pt) * | 2007-04-25 | 2025-10-23 | Opko Renal Llc | Método de tratamento e prevenção seguro e eficaz do hiperparatiroidismo secundário na doença renal crónica |
| PL2148661T3 (pl) | 2007-04-25 | 2013-07-31 | Cytochroma Inc | Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik |
| CN102046812A (zh) | 2008-04-02 | 2011-05-04 | 赛特克罗公司 | 用于维生素d缺乏症和相关障碍的方法、组合物、用途和试剂盒 |
| AU2013203489B2 (en) * | 2008-07-24 | 2015-02-05 | Wisconsin Alumni Research Foundation | Once-a-week administration of 25-hydroxy vitamin D3 to sustain elevated steady-state pharmacokinetic blood concentration |
| PT2552484T (pt) | 2010-03-29 | 2020-04-03 | Opko Ireland Global Holdings Ltd | Métodos e composições para redução dos níveis de parafróides |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) * | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| MY198547A (en) * | 2016-03-28 | 2023-09-04 | Opko Ireland Global Holdings Ltd | Methods of vitamin d treatment |
| MX2020010338A (es) * | 2018-04-03 | 2020-11-13 | Opko Ireland Global Holdings Ltd | Uso de calcifediol en pacientes de cirugia bariatrica. |
-
2020
- 2020-02-06 EP EP20713085.7A patent/EP3920938A1/en active Pending
- 2020-02-06 CA CA3128153A patent/CA3128153A1/en active Pending
- 2020-02-06 JP JP2021569596A patent/JP2022519789A/ja active Pending
- 2020-02-06 AU AU2020218639A patent/AU2020218639A1/en not_active Abandoned
- 2020-02-06 KR KR1020217026559A patent/KR20210126023A/ko not_active Ceased
- 2020-02-06 WO PCT/IB2020/000089 patent/WO2020161543A1/en not_active Ceased
- 2020-02-06 US US17/429,278 patent/US20220226351A1/en active Pending
- 2020-02-06 MX MX2020011741A patent/MX2020011741A/es unknown
- 2020-02-06 CN CN202080020844.6A patent/CN113573714A/zh active Pending
-
2024
- 2024-11-25 JP JP2024204631A patent/JP2025031720A/ja active Pending
-
2025
- 2025-10-30 AU AU2025259887A patent/AU2025259887A1/en active Pending